Box | Folder		Title
		Experiments by Series [subseries]:
		AE series, 1975
2	22	AE1, 4/3/75
2	23	AE2, 4/4/75
2	24	AE3, 4-9-75 (discarded)
2	25	AE4, 4-10-75
2	26	AE5, 4/14/75
2	27	AE6, 4-17-75
2	28	AE7, 4-28-75
2	29	AE8, 5-7-75
2	30	AE9, 5-8-75
2	31	AE10, 5-19-75
2	32	AE11, 5-20-75 (discarded)
2	33	AE12, 5-22-75
		AMP series, 1976
2	34	AMP -- behavior, 1976
2	35	D-AMP-DG-1, 6-8-76
2	36	D-AMP-DG-2, 6-16-76
2	37	D-AMP-DG-3, 6-18-76
2	38	D-AMP-4, 8-26-76
2	39	D-AMP-5, 8-26-76
2	40	D-AMP-6, 9-17-76
2	41	D-AMP-7, 12-23-76
2	42	D-AMP-8, 12-23-76
2	43	D-AMP-DG-101, 6-19-76
2	44	D-AMP-102, 6-28-76
2	45	D-AMP-103, 7-3-76
2	46	D-AMP-104, 7-3-76
2	47	D-AMP-105, 7-6-76
2	48	D-AMP-106, 7-7-76
2	49	D-AMP-107, 7-10-76
2	50	D-AMP-108, 7-20-76
2	51	D-AMP-109, 7-20-76
2	52	GU-BR, 1976
3	1	L-AMP-DG-1, 6-12-76
3	2	L-AMP-2, 10-22-76
3	3	L-AMP-3, 12-20-76
3	4	L-AMP-4, 12-21-76
3	5	L-AMP-5, 12-22-76
3	6	L-AMP-6, 12-22-76
3	7	L-AMP-7, 12-23-76
3	8	L-AMP-101, 7-12-76
3	9	L-AMP-102, 7-12-76
3	10	L-AMP-103, 7-15-76
3	11	L-AMP-104, 7-17-76
3	12	L-AMP-105, 7-17-76
		Antipyrine series, 1969-1976
3	13	Antipyrine [ ]-CBF control 1, 3-29-76
3	14	Antipyrine [ ]-CBF control 2, 4-2-76
3	15	Antipyrine [ ]-CBF control 3, 4-3-76
3	16	Antipyrine c14, [ ]-CBF control 4, 4-5-76
3	17	Antipyrine c14, [ ]-CBF control 5, 4-6-76
3	18	Antipyrine C14, [ ]-CBF control 6, 4-7-76
3	19	Antipyrine partition coefficient in dogs, 1969-1970
3	20	Antipyrine partition coefficient in rats [photograph, negative], 1970
3	21	ARF-8A, LCBF-antip.-1', control, 1975
3	22	Chromatography on antipyrine, n.d.
3	23	Laplace transforms for antip. Sq. wave, 1975-1976
3	24	Series [ ] --IOD: IODO-antip. part. coeff. in rats -- data corrected, 1976
3	25	Series [ ] --IOD; IODO-antip. part. coeff. in rats -- discarded, 1976
3	26	Technical information on IODO-antipyrine, 1976
		AR series, 1974-1975
3	27	AR-1, P-30' -- 60 uc, experimental, 1974
3	28	AR-1A, P-30' -- 60 uc control, 1974
3	29	AR-2, P-30' -- 60 uc, experimentals, 1974
3	30	AR-3, P-30' -- 60 uc, experimentals, 1974
3	31	AR-3A, P-30' -- 60 uc, control, 1974
3	32	AR-4, P-30' -- 80 uc, experimentals, 1974
3	33	AR-4A, P-30' -- 80 uc, control, 1974
3	34	AR-5, P-30' -- 80 uc, experimentals, 1974
3	35	AR-5A, P-30' -- 80 uc, control, 1974
3	36	AR-6, P-30' -- 80 uc, experimentals, 1974
3	37	AR-6A, P-30' -- 80 uc, control, 1974
3	38	AR-7, P-30' -- 80 uc, experimentals, 1974
3	39	AR-8, P-30' -- 80 uc, experimentals, 1974
3	40	AR-9, anesthesia -- P-30' -- 80 uc, experimentals, 1974
3	41	AR-10, anesthesia -- P-30' -- 80 uc, experimentals, 1974
3	42	AR-11, experimentals, 11-6-75
3	43	AR-12, experimentals, 12-6-75
3	44	AR-13, experimentals, 6-16-75
		ARF series, 1974-1976
3	45	ARF1 -- LCBF + BARB, 3-20-74
3	46	ARF2 -- LCBF + BARB, 3-20-74
3	47	ARF3 -- LCBF + BARB, 3-21-74
3	48	ARF4 -- LCBF + BARB, 3-21-74
3	49	ARF5, LCBF + BARB, 3-23-74
3	50	ARF-6, 6-16-75
3	51	ARF-7, 6-19-75
3	52	ARF-8, 6-23-75
3	53	ARF-11, 6-21-76
3	54	ARF-12, 6-21-76
3	55	ARF-13, 6-23-76
3	56	ARF-14, 6-23-76
3	57	ARF-15, 6-30-76
3	58	ARF-16, 7-6-76
		ATP series, 1964-1973
3	59	ATP assay protocol, n.d.
3	60	ATP assays of factor preps., 1966
3	61	Effects of thyroid hormone in vivo on protein biosynthesis -- book 1T, 1964
3	62	Effects of thyroxine in vivo [photographs, negatives], n.d.
3	63	In vivo effect of T4 on microsomal ATP ase (I), 1971
3	64	In vivo effect of T4 on microsomal ATP ase (2), 1972
3	65	In vivo effect of T4/T3 on microsomal ATP ase (3), 1973
3	66	In vivo effect of T4/T3 on microsomal ATPase (4), 1973
4	1	In vivo experiments, n.d.
4	2	Microsomal ATP ase -- prep book, 1970
4	3	Microsomal ATP ase 1, Apr. -- Oct., 1970
4	4	Microsomal ATP ase 2, Oct., 1970, 1970-1972
4	5	Microsomal ATP ase 3, 1971-1972
4	6	Microsomal ATP ase 4, 1972-1973
		Cat series, 1971-1981
4	7	Cat 1, LCGU 30', 1971
4	8	Cat 3, LCGU 35', 1971
4	9	Anest. Cat 4, 1974
4	10	Cat 101, 10-17-77
4	11	Cat 102, 10-20-77
4	12	Cat 103, 10-27-77
4	13	Cat 104, 11-17-77
4	14	Cat 105, 11-21-77
4	15	Cat 106, 12-1-77
4	16	Cat 107, 12-8-77
4	17	Cat 108, 12-15-77
4	18	Cat 109, 12-21-77
4	19	Cat 110, 12-29-77
4	20	Cat 111, Jan/12/78
4	21	Cat 112, 1-19-78
4	22	Cat 113, 1-26-78
4	23	Cat 114, 2-2-78
4	24	Cat 115, 2-9-78
4	25	Cat 116, 2-23-78
4	26	Cat 117, 3-2-78
4	27	Cat 118, 3-9-78
4	28	Cat 119, 3-14-78
4	29	Cat 120, 3-16-78
4	30	Cat 121, 3-23-78
4	31	Cat 122, 3-24-78
4	32	Cat 123, 3-28-78
4	33	Cat 124, 3-29-98
4	34	Cat awake, rem-4, rem-5, pc-1, 1980
4	35	Cat CBF 2, 1971
4	36	Cat, lumped constant, 1974
4	37	Normal cats, LCBF 1, 1971
4	38	Normal cat CBF 3, 1971
4	39	Normal cat CBF 4, 1971
4	40	Normal cat CBF 5, 1971
4	41	Normal - CFG cat CBF 6, 1971
4	42	SC-1, r. eye patched + 1 PS (P-45' -- 200 uc), 1973
4	43	SC-1A, both eyes patched (P-45 -- 220 uc), 1973
4	44	Series cat: cats -- 30 min. controls, 1980-1981
4	45	Series SQ, Cat 2 - 8 -- lumped constant in cats conscious, 1974-1976
4	46	SLC 1 (control for REM), 1975
4	47	SLC-2, control for REM, 1975
4	48	SLC-3, REM sleep cat, 1975
4	49	SLC-4, REM sleep cat, 1975
4	50	SLC-5, REM sleep cat, 1976
4	51	SQ -- Cat 1, anesth., 1974
4	52	SQ -- Cat 2, anesth., 1974
		Cerebral Blood Flow (CBF) series, 1953-1993
5	1	1 NMACO2 -- CBF series -- air breathing control, 1990
5	2	2 NMACO2 -- CBF series, air breathing control, 1990
5	3	3 NMACO2 -- CBF series, 5% CO2 in air, 1990
5	4	4 NMACO2 -- CBF series, 5% CO2 in air, 1990
5	5	5 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5	6	6 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5	7	7 NMACO2 -- CBF series, 5% C02 in air, 1990-1991
5	8	8 NMACO2 -- CBF series -- air breathing control, 1990
5	9	9 NMACO2 -- CBF series -- air + N methyl arginine, 1990
5	10	10 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5	11	11 NMACO2 -- CBF series -- air + N methyl arginine, 1990-1991
5	12	12 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5	13	13 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5	14	14 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5	15	15 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5	16	16 NMACO2 -- CBF series -- air breathing control, 1991
5	17	17 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5	18	18 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	19	19 NMACO2 -- CBF series -- air breathing control, 1991
5	20	20 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5	21	21 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	22	22 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5	23	23 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5	24	24 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	25	25 NMACO2 -- CBF series -- air breathing control, 1991
5	26	26 NMACO2 -- CBFG series -- air + N methyl arginine, 1991
5	27	27 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	28	28 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	29	29 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5	30	30 NMACO2 -- CBF series - - 5% CO2 + N methyl arginine (30 mg/kg), 1991
5	31	31 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	32	32 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	33	33 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	34	34 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5	35	35 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5	36	36 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	37	37 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	38	38 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5	39	39 NMACO2 -- CBF series -- air + saline, 1991
5	40	40 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (100 mg/kg), 1991
5	41	41 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5	42	42 NMACO2 -- CBF series -- air + N methyl arginine (100 mg/kg), 1991
5	43	43 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	44	44 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	45	45 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	46	46 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	47	47 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	48	48 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	49	49 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	50	50 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	51	51 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	52	52 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5	53	53 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5	54	54 NMACO2 -- CBF series -- air + saline, 1991
5	55	55 NMACO2 -- CBF series -- air + saline (eliminated), 1991
5	56	56 NMACO2 -- CBF series -- air + saline, 1991
5	57	57 NMACO2 -- CBF series -- air breathing control, 1991
5	58	58 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5	59	59 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5	60	60 NMACO2 -- CBF series -- air breathing control, 1991
5	61	61 NMACO2 -- CBF series -- air breathing control, 1991
5	62	62 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5	63	63 NMACO2 -- CBF series -- saline + 5% CO2, 1991
5	64	64 NMACO2 -- CBF series -- saline + air, 1991
5	65	65 NMACO2 -- CBF series -- saline + air, 1991
5	66	66 NMACO2 -- CBF series -- saline + 5%CO2, 1991
5	67	67 NMACO2 -- CBF series -- air + NMA (30 mg/kg), 1991
5	68	68 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5	69	69 NMACO2 -- CBF series --5% CO2 + NMA (10 mg/kg), 1991
5	70	70 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5	71	71 NMACO2 -- CBF series -- 5% CO2 + NMA (10 mg/kg), 1991
5	72	72 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5	73	NMA-73, NMA 10 mg/kg + air, 1992
5	74	NMA-74, NMA 10 mg/kg I.V + air, 1992
5	75	NMA-75, NMA 30 mg/kg I.V. + air, 1992
5	76	NMA-76, NMA 10 mg/kg I.V. + 5% CO2, 1992
5	77	77 NTRO-1, CO2 and saline I.V., 1992
5	78	78 NTRO-2, CO2 and nitro, 1992
5	79	79 NTRO-3, air and nitro 30 mg/kg i.v., 1992
5	80	80 NTRO-4, air and nitro, 1992
5	81	81 NTRO-5, CO2 and nitro, 1992
5	82	82 NTRO-6, CO2 and saline i.v., 1992
5	83	83 NTRO-7, CO2 and saline i.v., 1992
6	1	84 NTRO-8, CO2 and nitro, 1992
6	2	85 NTRO-9, air and nitro, 1992
6	3	86 NTRO-10, CO2 and nitro 30 mg/kg i.v., 1992
6	4	87 NTRO-11, air + nitro 30 mg/kg i.v., 1992
6	5	88 NTRO-12, CO2 and nitro 30 mg/kg i.v., 1992
6	6	89 NTRO-13, air and nitro, 1992
6	7	90 NTRO-14, air and nitro, 1992
6	8	91 NTRO-15, CO2 and nitro, 1992
6	9	92 NTRO-16, CO2 and nitro, 1992
6	10	93 NTRO-17, 5% CO2 and nitro 30 mg/kg, 1992
6	11	95 NTRO-19, 5% CO2 and nitro 30 mg/kg i.v., 1992
6	12	96 NTRO-20, nitro-topical, 1992
6	13	97 NTRO-21, nitro-topical, 1992
6	14	98 NTRO-22, nitro-topical, 1992
6	15	98 NTRO-23, nitro-topical, 1992
6	16	100 NTRO-24s, air and nitro 30 mg/kg, 1993
6	17	101 NTRO-25s, air + nitro 30 mg/kg, 1993
6	18	102 NTRO-26s, 5% CO2 and nitro 30 mg/kg i.v., 1993
6	19	103 NTRO-27s, nitro 30 mg/g i.v. and 5% CO2, 1993
6	20	104 (28), CO2 and NTRO, 1993
6	21	105 (29), CO2 and NTRO, 1993
6	22	106 (30), air and NTRO, 1993
6	23	107 (31), air and NTRO, 1993
6	24	NTRO 108, chronic i.p. and CO2, 1993
6	25	NTRO 109, chronic i.p. and CO2, 1993
6	26	NTRO 110, chronic i.p. and air, 1993
6	27	NTRO 111, chronic i.p. and air, 1993
6	28	NTRO 112, chronic i.p. and air, 1993
6	29	NTRO 113, chronic i.p. and CO2, 1993
6	30	NTRO 114, chronic i.p. and CO2, 1993
6	31	NTRO 115, chronic i.p. and CO2, 1993
6	32	NTRO 116, chronic i.p. and air, 1993
6	33	NTRO 117, chronic i.p. and air, 1993
6	34	NTRO 118, chronic i.p. and air, 1993
6	35	NTRO 119, chronic i.p. and CO2, 1993
6	36	NTRO 120, saline chronic i.p. and CO2, 1993
6	37	NTRO 121, saline chronic i.p. and CO2, 1993
6	38	NTRO 122, saline chronic i.p. and air, 1993
6	39	NTRO 123, saline chronic i.p. and air, 1993
6	40	NTRO 124, saline chronic i.p. and air, 1993
6	41	NTRO 125, saline chronic i.p. and CO2, 1993
6	42	NTRO 126, 1993
6	43	NTRO 127, 1993
6	44	NTRO 128, 1993
6	45	NTRO 129, 1993
6	46	NTRO 130, 1993
6	47	NTRO 131, saline chronic i.p. and CO2, 1993
6	48	NTRO 132, saline chronic i.p. and CO2, 1993
6	49	NTRO 133, saline chronic i.p. and CO2, 1993
6	50	14c-NMA distribution, 1993
6	51	Brain tissue NMA assay, 1992
6	52	Calculations for CBF (Kety-Schmidt), n.d.
6	53	CBF -- ischemia experiments, 1980
6	54	CBF -- LSD -- normals, 1954-1955
6	55	CBF -- n.20 -- normal young, 1957-1958
6	56	CBF -- nitrous oxide - Pitressin, 1956
6	57	CBF -- nitrous oxide -- children [photographs], 1957
6	58	CBF -- thyroid disease, n.d.
6	59	CBF aged -- continued, 1956-1957
6	60	CBF exp., n.d.
6	61	CBF lysergic acid [photographs], 1955
6	62	Cerebral blood flow, 1957-1958
6	63	Cerebral blood flow -- book II, 1954-1957
6	64	Cerebral blood flow 3, 1955
6	65	Changes in CBF during REM sleep (fig. 3) (from Reivitch, et. al.) [slides], 1977
6	66	Chemical assay in NMA study, 1992
6	67	CO2 study -- local CBF, n.d.
6	68	CBF -- LSD -- schizophrenia, 1954-1955
6	69	KR 79 CBF studies [photographs], 1953-1955
6	70	Local C.B.F III, 1954-1955
6	71	Local C.B.F. II, 1953-1954
6	72	Local C.B.V IV, 1955-1957
6	73	NMA Co2 series, n.d.
6	74	NMA2DG series: animal 01 control, 1991
6	75	NMA2DG series: animal 02, exp. NMA 3 mg., 1991
6	76	NMA2DG series: animal 3, exp. NMA 3 mg/kg, 1991
6	77	NMA2DG series: animal 4 control, 1991
6	78	NMA2DG series: animal 05, exp. NMA 3mg/kg, 1991
6	79	NMA2DG series: animal 06 control, 1991
6	80	NMA2DG series: animal 07, exp. NMA 3mg/kg, 1991
6	81	NMA2DG series: animal 08 control, 1991
6	82	NMA2DG series: animal 09 control, 1991
6	83	NMA2DG series: animal 10 control (eliminated), 1991
7	1	NMA2DG series: animal 11 control, 1991
7	2	NMA2DG series: animal 12 control, 1991
7	3	NMA2DG series: animal 13 control, 1991
7	4	NMA2DG series: animal 14, exp. NMA 100 mg/kg, 1991
7	5	NMA2DG series: animal 15, exp. NMA 100 mg/kg, 1991
7	6	NMA2DG series: animal 16 control, 1991
7	7	NMA2DG series: animal 17, exp. NMA 100 mg/kg, 1991
7	8	NMA2DG series: animal 18 control, 1991
7	9	NMA2DG series: animal 19, exp. NMA 100 mg/kg, 1991
7	10	NMA2DG series: animal 20, exp. NMA 100 mg/kg, 1991
7	11	NMA2DG series: animal 21, exp. NMA 100 mg/kg, 1991
7	12	NMACO2 summaries, 1992
7	13	NMA-DG, data sheet, 1991-1992
7	14	Regional cerebral blood flow (Tbl 2) (from Reivitch, et. al.), 1977
		CI* series
7	15	Ci *(t)/Cp*(t) vs. stretch time <pulse experiments>, 1979
7	16	Ci ct/Cp* vs. real time or stretch time -- weighted average, 1979-1985
7	17	Ci*(t)/Cp*(t) vs. stretch time (pulse experiments), n.d.
7	18	Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 1 of 2], 1979-1986
7	19	Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 2 of 2], 1979-1986
7	20	Local tissue 14c concentration (white) -- Ci ct/Cp* (white), 1975-1985
7	21	Lt Cp*dt -- pulse exp., 1979
7	22	Pulse (mori) -- local Ci* - ci*/Cp*, 1979-1984
7	23	Square wave experiments -- Ci*(t)/Cp*(t) vs. stretch time -- vs. real time Ci*(t)/Cp*, n.d.
7	24	Weighted average -- Ci*(t)/Cp*(t) vs. stretch time -- pulse experiments, 1979
		CR series, 1972-1976
7	25	CB-4, B-20 uc -- 45', CO2 -- 86', 1975
7	26	CB-5, B-20 uc -- 45', CO2 -- 86', 1975
7	27	CB-6, Pul. -- 20 uc -- 45', CO2 -- 90', 1975
7	28	CB-7, LCGU-45' -- 30 uc, CO2 -- 75', 1975
7	29	CB-8, discarded, 1975
7	30	CB-9, LCGU -- 45' -- 30 uc, CO2 -- 75', 1975
7	31	Series CRO: 5% CO2, 45' exposure, n.d.
7	32	CR-1, LCGU + CO2, P-30' 80 uc, 1974
7	33	CR-2, LCGU + CO2, P-30' -- 80 uc, 1974
7	34	CR-3, LCGU + CO2, P-30' -- 80 uc, 1974
7	35	CR-4, LCGU + CO2, P-33' -- 90 uc, 1974
7	36	CR-5, LCGU + CO2, P-30' -- 90 uc, 1974
7	37	CR-101, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7	38	CR-102, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7	39	CR-103, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7	40	CR-104, LCGU -- 30' -- 50 uci, CO2 -- 45', 1975
7	41	CR-105, LCGU -- 30' -- 70 uci, CO2 -- 45', 1975
7	42	CRF-1, 85 uc, LCBF + CO2-74 min., 1974
7	43	CRF-2, 85 uc, LCBF + CO2 -- 70', 1974
7	44	CRF-3, 85 uc, LCBF + CO2 -- 45', 1974
7	45	CRF-4, 68 uc, LCBF + CO2 -- 48', 1974
7	46	CRF-5, 68 uc, LCBF + CO2 -- 45', 1974
7	47	CRF-6, 85 uc, LCBF + CO2 -- 41', 1974
7	48	CRF-7, 85 uc, LCBF + CO2 -- 26', 1974
7	49	CRF-8, 85 uc, LCBF + CO2 -- 38', 1974
7	50	CRF-9, 85 uc, LCBF + CO2 -- 43', 1974
7	51	CRF-10, 85 uc, LCBF + CO2 -- 42', 1974
7	52	CRF-11, 85 uc, LCBF + CO2 -- 11', 1975
7	53	CRF-12, 85 uc, LCBF + CO2 -- 12', 1975
7	54	CRF-13, 85 uc, LCBF + CO2 -- 12', 1975
7	55	CRF-14, 85 uc, LCBF + CO2 -- 16', 1975
7	56	CRF-15, 68 uc, LCBF + CO2 -- 14', 1975
7	57	CRF-101, LCBF -- 1', 10% CO2 -- 45', 1975
7	58	CRF-102, LCBF -- 1', 10% CO2 -- 45', 1975
7	59	CRF-103, LCBF -- 1', 10% CO2 -- 45', 1975
7	60	CRF-104, LCBF -- 1', 10% CO2 -- 45', 1975
7	61	CRF-105, LCBF (Ant. 1'), 10% CO2 -- 45', 1975
7	62	Series CRF 111-115 : 10% CO2 + 10' exposure, 1975
7	63	CRF-201, 20% CO2, 1976
7	64	L.C.B.F. : effects of CO2 in puppy, 1972
		DEX series, 1979
8	1	Dex-1, 1-30-79
8	2	Dex-2, 3-12-79
8	3	Dex-3, 3-14-79
8	4	Dex-4, 3-16-79
8	5	DEx-5, 4-19-79
8	6	Dex-Px-1 (21 mg/kg), 1-15-79
8	7	Dex-Px-2 (21 mg/kg), 3-12-79
8	8	Dex-Px-3 (21 mg/kg/min.), 3-14-79
8	9	Dex-Px-4 (21 mg/kg), 3-16-79
8	10	Dex-Px-5 (21 mg/kg), 3-21-79
		Deoxyglucose (DG) series, 1973-1979
8	11	% of free DG in grey and white matter, 1977
8	12	DG-1, 30' -- B, 1973
8	13	DG-2 (C14), 1973
8	14	DG-3, 45' cont., 1973
8	15	DG-101, 30' -- B, 1973
8	16	DG-102, B -- 30' -- 51 uc, 1973
8	17	DG-103, B-45'-76 uc, 1973
8	18	DG-104, B-45' -- 76 uc, 1973
8	19	DG-105 B-120' (51 uc x 1 ½'), 1973
8	20	DG-106, B-45' -- 51 uc, 1973
8	21	DG-107 B-120" (51 uc x 1 ½'), 1973
8	22	DG-108, B-45' -- 51 uc, 1973
8	23	DG-111, B-75' -- 51 uc, 1973
8	24	DG-112, B-75 -- 51 uc, 1973
8	25	DG-113, B-90' -- 51 uc, 1973
8	26	DG-114, B-90' -- 51 uc, 1973
8	27	DG-115, LCGU -- control 45', 1975
8	28	DG-116, LCGU -- control 45' (30 uc), 1975
8	29	DG-117, LCGU -- 30' -- 50 uc, 1975
8	30	DG-118, LCGU -- 30', control, 1975
8	31	DG-119, LCGU -- 30' -- 50 uc, control, 1975
8	32	DG-120, LCGU -- 30' -- 50 uc, control, 1975
8	33	DG-121, normal control 45', 1976
8	34	DG-125, LCGU normal control rat, 30', 1976
8	35	DG-126, LCGU -- normal control rat 45', 1976
8	36	DG-127, LCGU -- normal control, 45', 1976
8	37	DG-128, LCGU -- normal control rat, 45', 1976
8	38	DG-129, LCGU -- normal control rat, 45', 1976
8	39	DG-130, LCGU -- normal control, 30', 1976
8	40	DG-131, LCGU -- normal control, 30', 1976
8	41	DG-132, LCGU normal control, 30', 1976
8	42	DG-133, LCGU -- normal control, 30', 1976
8	43	DG-134, LCGU -- normal control rat, 45' (discarded), 1976
8	44	DG-135, LCGU -- light flow rate of anesthetic gas mixture, 45', 1976
8	45	DG-137, LCGU -- tight mask + high flow rate of anesthetic gas mixture, 30', 1976
8	46	DG-138, normal control rat, 45', 1976
8	47	DG-141, high flow rate of gas mix with tight mask, 30', 1976
8	48	DG-142, low flow rate of gas mix with loose mask, 30', 1976
8	49	DG-143, normal control rat, 45', 1976
8	50	DG-144, normal control rat, 45', 1976
8	51	DG-145, normal control rat, 45', 1976
8	52	DG-146, normal control rat, 45', 1976
8	53	DG-147, normal control rat, 45' (discarded), 1976
8	54	DG-170, 8-16-77
8	55	DG-182, 45 min. (C.K.) 7-27-78
8	56	DG-183, 30 min. (C.K.) 7-27-78
8	57	DG-184, 7-27-78, 20 min. C.K.
8	58	DG-185, 45 m in. (C.K.) 7-31-78
8	59	DG-186, 30 min. (C.K.) 7-31-78
8	60	DG-190, 45 min. (C.K.) 9-11-78
8	61	DG-191, 9-11-78, 20' control
8	62	DG-192, 60 min. (C.K.) 9-14-78
8	63	DG-193, 45 min. (C.K.) 9-18-78
8	64	DG-194, 90 min. (C.K.) 9-21-78
8	65	DG-195, 9-21-78, 20 min. C.K.
8	66	DG-196, 10-2-78, 20 min. C.K.
8	67	DG-198, 30 min. (C.K.) 10-5-78
8	68	DG-199, 10-16-78, 20 min. C.K.
9	1	DG-200, 30 min (C.K.) 10-16-78
9	2	DG-201, 45 min. (C.K.) 10-19-78
9	3	DG-201, 5' -- C -- 51 uc, 1973
9	4	DG-202, 60 min (C.K.) 10-19-78
9	5	DG-202., 5' -- C -- 51 uc, 1973
9	6	DG-203, 10' -- C 39 uc, 1973
9	7	DG-203, 90 min. 10-23-78
9	8	DG-204, 10' -- C 39 uc, 1973
9	9	DG-204, 60 min. 10-23-78
9	10	DG-205, 10' -- C -- 39 uc, 1973
9	11	DG-205, 60 min. control, 1978
9	12	DG-206, 5' -- C 51 uc, 1973
9	13	DG-207, 10' -- C -- 39 uc, 1973
9	14	DG-207, 60 min. 12-22-78
9	15	DG-208, 20' -- C -- 34 uc, 1973
9	16	DG-209, 20' -- C -- 34 uc, 1973
9	17	DG-209, 45 min. (C.K.) 12-28-78
9	18	DG-210, 20' -- C -- 34 uc, 1973
9	19	DG-210, 30 min 12-28-78
9	20	DG-211, 1-4-79, 20 min. control
9	21	DG-211, C -- 30' -- 29 uc, 1973
9	22	DG-212, 30' -- C -- 29 uc, 1973
9	23	DG-212, 90 min. 1-11-79
9	24	DG-213, 90 min. 1-15-79
9	25	DG-213, C -- 30' -- 29 uc, 1973
9	26	DG-214, 90 min. 1-18-79
9	27	DG-214, C -- 45' -- 23 uc, 1973
9	28	DG-215, 90 min. 1-18-79
9	29	DG-215, C -- 45' -- 23 uc, 1973
9	30	DG-216, C -- 1' -- 68 uc, 1973
9	31	DGX-1, BoP. -- 6 hrs., 1973
9	32	DGX-2, BoP. -- 17 hrs., 1973
9	33	DGX-3, BoP -- 24 hrs., 1973
9	34	Summary of DGX-1, DGX-2, DGX-3 data, 1973
		DL series, 1971-1973
9	35	DL-X, 1972
9	36	Series DL1 -- DL11 : 20 mg/kg, experimentals, 1971
9	37	Series DL 1A -- DL 11A : 20 mg/kg controls, 1972
9	38	Series DL101 -- DL110 : 100 mg/kg, experimentals, 1971
9	39	Series DL201-DL206 : 50 mg/kg, experimental, 1972
9	40	Series DL207A -- DL215A : 50 mg/kg, controls, 1972
9	41	Series DL208 -- DL211 : 50 mg/kg, experimentals, 1972
9	42	Series DL213 -- DL214 : 50 mg/kg, experimentals, 1975
9	43	Series DL301 and DL302 : 50 mg/kg, experimental, 1972
9	44	Series DL301A -- DL303A : 50 mg/kg, controls, 1972
9	45	Series DL304 -- DL307 : 50 mg/kg, experimentals, 1972
9	46	Series DL306A -- DL309A : 50 mg/kg, controls, 1972-1973
9	47	Series DL-309 : 50 mg/kg, experimentals, 1973
		E/E series, 1974-1975
9	48	E/E 1and2, discarded, 1974
9	49	E/E 3, 1974
9	50	E/E 4, 1974
9	51	E/E 5, 1974
9	52	E/E 6, 1974
9	53	Rat E/E 7, 1974
9	54	E/E 8, 11-7-74
9	55	E/E 9, 11-14-74
9	56	E/E 10, 12-12-74
9	57	E/E 11, 1974
9	58	E/E 12, 1974
9	59	E/E 13, Jan. 10, 1975
9	60	E/E 14, 1-13-75
9	61	E/E 15, 1-17-75
9	62	E/E 16, 1-23-75
9	63	E/E 17, 1-27-75
9	64	E/E 18, 2-6-75
9	65	E/E 19, 2-10-75
9	66	E/E 20, 2-13-75
9	67	E/E 21, Feb. 14, '75
9	68	E/E 26, and 27, cancelled, 1975
9	69	E/E 29 discarded, 1975
		G6 series, 1985, 1987
9	70	G6 pase 1, 1985
9	71	G6 pase 2, 1985
9	72	G6 pase 3, 1985
9	73	G6 pase 4, 1985
9	74	G6 pase 5, 1985
9	75	G6 pase 6, 1985
9	76	GA pase 7, 1985
9	77	G6 pase 8, 1985
9	78	G6 pase 9, 1985
9	79	G6 pase 10, 1985
9	80	G6 pase 11, 1985
9	81	G6 pase 12, 1985
9	82	G6 pase 13 -- Aug. 2, 85
9	83	G6 pase 14, 1985
9	84	G6 pase 15, 1985
9	85	G6 pase 16, 1985
9	86	G6 0ase 17 -- Aug. 5, 85
9	87	G6 pase 18 -- Aug. 5, 85
9	88	G6 pase 19 -- Aug.; 5, 85
9	89	G6 pase 20 -- Aug. 5, 85
9	90	G6 pase 21 -- Aug. 1, 85
9	91	G6 pase 22 -- Aug. 6, 85
9	92	G6 pase 23 -- Aug. 6, 85
9	93	G6 pase 24 -- Aug. 6, 85
9	94	G6 pase 25 -- Aug. 7, 85
9	95	G6 pase 26 -- Aug. 7, 85
9	96	G6 pase 27 -- Aug. 7, 85
9	97	G6 pase 28 -- Aug, 7, 85
9	98	G6 pase 29 -- Aug. 8, 85
10	1	G6 pase 30 -- Aug. 8, 85
10	2	G6 pase 31 -- Aug. 8, 85
10	3	G6 pase 32 -- Aug. 8, 85
10	4	G6 pase 33 -- Aug. 9, 85
10	5	G6 pase 34 -- Aug. 9, 85
10	6	G6 pase 35 -- Aug. 9, 85
10	7	G6 pase 36 -- Aug. 9, 85
10	8	G6 pase 37 -- Aug. 10, 85
10	9	G6 pase 38 -- Aug. 10, 85
10	10	G6 pase 39, 1985
10	11	G6 pase 40, 1985
10	12	G6 pase 41, 1985
10	13	G6 pase 42 -- 60 min. -- Aug. 13, 1985
10	14	G6 pase 43, 1985
10	15	G6 pase 44 -- Aug. 14, 85
10	16	G6 pase 45 -- 90 min. -- Aug. 14, 85
10	17	G6 pase 46 -- 2.5 min. -- Aug. 14, 85
10	18	G6 pase 47 -- 15 min. -- Aug. 14, 85
10	19	G6 pase 48 -- 60 min. Aug. 16, 85
10	20	G6 pase 49 -- 30 min. -- Aug. 16, 85
10	21	G6 pase 50 -- 15 min. -- Aug. 16, 85
10	22	G6 pase 51 -- Aug. 17, 85
10	23	G6 pase 52 -- Oct. 16, 85
10	24	G6 pase 53 -- Oct. 16, 85
10	25	G6 pase 54 -- Nov. 27, 85
10	26	G6 pase 55 -- Nov. 27, 85
10	27	G6 pase 56 -- Nov. 29, 85
10	28	G6 pase 57 -- Nov. 29, 85
10	29	G6 pase 58 -- Nov. 29, 85
10	30	G6 pase P1 -- Aug. 15, 85
10	31	G6 pase P2 -- Aug. 15, 85
10	32	G6 pase P3 -- Aug. 16, 85
10	33	G6 pase P4 -- Aug. 16, 85
10	34	G6 pase P5 -- Aug. 16, 85
10	35	G6 pase P6 -- Aug. 27, 85
10	36	G6 pase P7 -- Aug. 85
10	37	G6 pase, 1985
10	38	G6 pase -- vol. I -- no. 1 -- no. 13, 1985
10	39	G6 pase -- vol. II -- no. 14 -- no. 25, 1985
10	40	G6 pase -- vol. III -- no. 26 -- no. 37, 1985
10	41	G6 pase -- vol. IV -- no. 38 -- no. 49, 1985
10	42	G6 pase -- P -- vol V, 1985
10	43	G6 pase -- vol. VI -- no. 50, 1985
10	44	G6 pase (square) -- anova, 1987
10	45	Physiological conditions -- G6 pase 1~58, n.d.
		HLNC series, 1976
10	46	Helen and Larry normal control series, n.d.
10	47	HLNC-DG-1, 6-25-76
10	48	HLNC-DG-2, 6-25-76, discarded
10	49	HLNC-3, 6-28-76
10	50	HLNC-4, 7-1-76
10	51	HLNC-5, 7-2-76
10	52	HLNC-6, 7-6-76
10	53	HLNC-7, 7-10-76
10	54	HLNC-8, 8-24-76
10	55	HLNC-9, 8-24-76
10	56	HLNC-10, 10-22-76
10	57	HLNC-11, 12-18-76
10	58	HLNC-12, 12-18-76
10	59	HLNC-13, 12-20-76
10	60	HLNC-14, 12-21-76
10	61	HLNC-15, 12-22-76
		HIG series, 1977-1978
10	62	HIG-1, 11-28-77
10	63	HIG-2, 11-28-77
10	64	HIG-3, 12-2-77
10	65	HIG-4, 5-11-78
10	66	HIG-5, 5-31-78
10	67	HIG-NS-1, 1-11-78
10	68	HIG-saline-2, 2-7-78
10	69	HIG-saline-9, 7-12-78
11	1	Nacl-01, 6-22-78
11	2	Nacl-03, 7-10-78
11	3	Nacl-04, 7-11-78
11	4	Nacl-05, 7-12-78
11	5	Nacl-3, 2-13-78
11	6	Nacl-4, 2-22-78
11	7	Nacl-5, 4-4-78
11	8	Nacl-6, 4-18-78
11	9	Nacl-7, 5-3-78
11	10	Nacl-8, 5-10-78
		Hyperglycemia (LC) series, 1980-1987
11	11	LC -- hyperglycemia 1, 15 Jan. '80
11	12	LC -- hyperglycemia 2, 28 Jan '80
11	13	LC -- hyperglycemia 3, Feb. 1 '80
11	14	LC -- hyperglycemia 4, 2/3/80
11	15	LC -- hyperglycemia 5, 2/6/80 -- Franz, Francesco, Jane, Esther, Sumio
11	16	LC -- hyperglycemia 6, 2/20/80
11	17	LC -- hyperglycemia 7, 3/3/80 -- Franz, Francesco, Jane, Esther, Sumio
11	18	LC -- hyperglycemia 8, 3/12/80 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane Jehle, Esther
11	19	LC -- hyperglyc. 9, 3/18/80 -- Franz, Francesco, Sumio, Jane, Dr. Kennedy, Wolfgang, Esther
11	20	LC -- hyperglycemia 10, 3/27/80 -- Franz, Francesco, Sumio, Esther, Wolfgang, Dr. Kennedy
11	21	LC -- hyperglycemia 11, 3/31/80 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane
11	22	LC -- hyperglycemia 12, 4/22/80 -- Franz, Francesco, Sumio, Jane Jehle, Esther
11	23	LC -- hyperglycemia 13, 4/29/80 -- Franz, Francesco, Sumio, Jane, Esther
11	24	LC -- hyperglycemia 14, 5/6/80 -- Franz, Francesco, Sumio, Jane, Esther
11	25	LC -- hyperglycemia 15, 5/8/80 -- Franz, Francesco, Sumio, Jane, Esther
11	26	LC -- hyperglycemia 16, 5/13/80 -- Franz, Francesco, Jane, Esther
11	27	LC -- hyperglycemia 17, 5/19/80 -- Franz, Francesco, Sumio, Jane, Esther
11	28	LC -- hyperglycemia 18, 5/21/80 -- Franz, Francesco, Sumio, Jane
11	29	LC -- hyperglycemia 19, 5/23/80 -- Franz, Francesco, Sumio, Jane, Esther
11	30	LC -- hyperglycemia 20, 5/30/80 -- Franz, Francesco, Jane, Sumio, Esther
11	31	LC -- hyperglycemia 21, 5/30/80 -- Franz, Francesco, Jane, Sumio
11	32	LC -- hyperglycemia 22, 6/9/80 -- Franz, Francesco, Jane
11	33	LC -- hyperglycemia 23, 6/11/80 -- Franz, Francesco, Jane
11	34	LC -- hyperglycemia 24, 6/16/80 -- Franz, Francesco, Jane
11	35	LC -- hyperglycemia 25, 6/19/80 -- Franz, Francesco, Jane
11	36	LC -- hyperglycemia 26, 6/25/80 -- Franz, Francesco, Jane
11	37	LC -- hyperglycemia 27, 7/1/80 -- Franz, Francesco, Jane, Esther
11	38	LC -- hyperglycemia 28, 7/8/80 -- Franz, Francesco, Sumio, Jane, Esther
11	39	LC -- hyperglycemia 29, 7/10/80 -- Franz, Francesco, Jane, Esther
11	40	LC -- hyperglycemia 30, 7/17/80 -- Franz, Francesco, Jane, Esther
11	41	LC -- hyperglycemia 31, 7/21/80 -- Franz, Francesco, Jane, Esther
11	42	LC -- hyperglycemia 32, 7/24/80 -- Franz, Francesco, Jane, Sumio, Esther
11	43	LC- hyperglycemia -- compiled data, 1980-1987
11	44	LC -- hyperglycemia -- error analyses, counting procedures, etc., 1980
11	45	LC table -- species, n.d.
		Iodoantipyrine (IOD) series, 1976-1977
11	46	Iodoantipyrine [ ]-CBF control 1, 4-1-76
11	47	Iodoantipyrine [ ]-CBF control 2, 4-2-76
11	48	Iodoantipyrine [ ]-CBF control 3, 4-3-76
11	49	14c -- iodoantiyprine, [ ]-CBF control 4, 4-6-76
11	50	14c -- iodoantipyrine, [ ]-CBF control 5, 4-6-76
11	51	14c -- iodoantipyrine -- [ ]-CBF control 6, 4-7-76
11	52	Chromatography for 14c -- iodoantipyrine -- 7-7-76
11	53	Chromatography of iodoantipyrin experiment -- by J. D. Brown, 1976
11	54	Dissolve of 14c -- iodoantipyrine into dioxane phosphov., n.d.
11	55	IOD-C-7, 14c iodoantiyprine normal cat -- 8-19-76
11	56	IOD-C-8, 1-6-77
11	57	Iodoantipyrine cat normal control 1, 5-6-76
11	58	Iodoantipyrine cat normal control 2, 5-14-76
11	59	Iodoantipyrine normal CBF cat 3, 5-20-76
11	60	Iodoantipyrine normal control 4, 5-27-76
11	61	Iodoantipyrine cat normal control 5, 6-4-76
11	62	Iodoantipyrine cat normal control 6, 6-11-76
11	63	Iodoantipyrine cat study summary, n.d.
11	64	Iodoantipyrine solubility property, n.d.
11	65	Iodoantipyrine study summary, n.d.
11	66	Iodoantipyrine, radiochromatogram - CFG 1265, 1976
11	67	Iodoantipyrine, radiochromatogram -- CFQ 1460, 1976
		IP series, 1993
11	68	IPBF 1-4, 1993
11	69	IPBF 5-8, 1993
11	70	IPBF 9-12, 1993
11	71	IPBF 13-16, 1993
11	72	IPBF 17-20, 1993
12	1	IPBF 21-24, 1993
12	2	IPBF 25-28, 1994
12	3	IPBF 29-32, 1994
12	4	IPDG 2 L-NAME, 1993
12	5	IPDG 3 L-NAME, 1993
12	6	IPDG 4 saline, 1993
12	7	IPDG 5, saline, 1993
12	8	IPDG 6, L-NAME, 1993
12	9	IPDG 7, L-NAME, 1993
12	10	IPDG 8, saline, 1993
12	11	IPDG 9, saline, 1993
12	12	IPDG 10, L-NAME, 1993
12	13	IPDG 11, saline, 1993
12	14	IPDG 12, saline, 1993
12	15	IPDG 13, L-NAME, 1993
12	16	IPDG 14, saline, 1993
12	17	IPDG 15, saline, 1993
12	18	IPDG 16, L-NAME, 1993
12	19	IPDG 17, saline, 1993
12	20	IPDG 18, saline, 1993
		KSA series, 1975-1976
12	21	Antipyrine chromatography, KSA 101 and 102 (plasma), 1975
12	22	Series KSA-0: antipyrine for BDBF pulse inf. for laplace transf., n.d.
12	23	KSA-101, CBF (K-s) antipyrine, sq. wave 60', 1975
12	24	KSA-102, CBF (K-S) antipyrine, sq. wave 35', 1975
12	25	KSA-103, CBF (K-S) antipyrine, pulse-50 uc-60', 1975
12	26	KSA-103: chromatography on plasma and brain, 1976
12	27	KSA-104 and 105, in brain and plasma, 1976
12	28	KSA-104, discarded, 1976
12	29	KSA-105, discarded, 1976
12	30	KSA-106, discarded, 1976
12	31	KSA-107, discarded, 1976
12	32	KSA-108, discarded, n.d.
12	33	KSA-109, discarded, 1976
12	34	KSA-110, discarded, 1976
12	35	KSA-114, discarded, 1976
12	35	KSA-118, discarded, 1976
12	37	KSA-119, discarded, 1976
12	38	KSA-120, discarded, 1976
12	39	KSA-124, n.d.
12	40	KSA-127, discarded, 1976
12	41	KSA-128, discarded, 1977
12	42	KSA-129, normal control (immobilization), 1977
12	43	KSA-131, 5% CO2, CBF, 1977
12	44	KSA-132, normal control, 1977
12	45	KSM-101, methylglucose as tracer for GCBF, 1975
12	46	KSM-102, methylglucose as tracer for GCBF, 1975
12	47	Series KSH: hippuric acid as tracer for GCBF, 1976
12	48	Series KSM1 -- KSM3: methylglucose as tracer for GCBF, 1975
		Lidocaine (Lido) series, 1978-1979
12	49	Lido-1, 7/24/78, control
12	50	Lido-1', 7/24/78
12	51	Lido-2, 8/3/78
12	52	Lido-3, 8/10/78, 2 lidocaine
12	53	Lido-4, 8-10-78, 1 lidocaine
12	54	Lido-5, 1-11-79, saline control
12	55	Lido-5', 1-11-79, no seizure history
12	56	Lido-6, 1-12-79, saline
12	57	Lido-6', 1-12-79, lidocaine
12	58	Lido-7, 1-19-79, saline
12	59	Lido-7', 1-19-79, lidocaine
12	60	Lido-8, 1-25-79, saline
12	61	Lido-8', 1-25-79, lidocaine
12	62	Lido-9, 1-26-79, saline
12	63	Lido-9' (experimental animal) 1-26-79
12	64	Lido-10, 2-1-79, saline control
12	65	Lido-10', 2-1-79, lidocaine
12	66	Lido-11, 2-2-79, saline control
12	67	Lido-11', 2-2-79, lidocaine
12	68	Lido-12, 2-15-79, saline
12	69	Lido-12', 2-15-79, lidocaine
12	70	Lido-13, saline, 2-16-79
12	71	Lido-13', lidocaine, 2-16-79
12	72	Lidocaine summary, 1979
		Glucose Utilization (LCGU) series, 1977-1987
12	73	Cerebral structure w/ signif. changes in LCGU at higher doses of D-LSD, 1976-1977
12	74	Effects of LSD on LCGU in individual structures as a function of dose, n.d.
12	75	Experiments -- hyperglycemia R.C. average, 1984
12	76	Free moving immobilization on LCGU and LCBF, 1978
12	77	Glucose / LCGU : from 0' -- 120', n.d.
12	78	Hyperglycemia LCGU experiments -- excluded and misc. [folder 1 of 2], 1980-1982
13	1	Hyperglycemia LCGU experiments -- excluded and misc. [folder 2 of 2], 1980-1982
13	2	Hyperglycemia LCGU experiments -- used and tables, 1982
13	3	Hyperglycemia LCGU experiments 450, 1984
13	4	Hyperglycemia LCGU experiments 450 (programming changes), 1984
13	5	Hyperglycemia LCGU experiments 550A, 1984
13	6	Hyperglycemia, 2DG, 450's, 1984
13	7	L.C.G.U. (pulse exp.) parameters: new 3 rate constants, 1986
13	8	L.C.G.U. (pulse experiments) from Dr. Shinohara's data representative structures, 1977
13	9	LCGU -- pulse experiments -- LC=0.483 -- parameters: new 3 rate constants, 1986
13	10	LCGU -- sandro, n.d.
13	11	LCGU -- taro, n.d.
13	12	LCGU (pulse experiments) -- 5 rate constants (K4*=0.002), 1986
13	13	LCGU (pulse experiments) Shinohara series -- graphs -- representative structures, 1977
13	14	LCGU (pulse) parameters 5 rate constants (K4*=0.0014), 1986
13	15	LCGU (square exp.) parameters 5 rate constants (K4*=0.001), 1986
13	16	LCGU (square wave experiments) graphs, n.d.
13	17	LCGU (square wave experiments) gray structures, n.d.
13	18	LCGU (square wave experiments) white structures, n.d.
13	19	LCGU hyperglycemia experiments -- Franz, Francesco, 1980
13	20	LCGU pulse experiments -- 5 rate constants (K4*=0.001), 1986
13	21-23	Local Cerebral Glucose Utilization, 1987
13	24	Shinohara pulse data -- LCGU w/5 -- H model -- K4=.002, K5=.05, 1986
13	25	Spinal cord (sleep) -- LCGU, n.d.
13	26	Summary of LCGU (pulse) with original rate constants, 1987
13	27	Summary of local LCGU -- square wave exp., n.d.
13	28	Table for LCGU value, n.d.
13	29	The effect of NMA on LCGU in the rat, n.d.
13	30	Weighted average LCGU -- pulse experiments, n.d.
		LS series, 1977-1979
14	1	LS-11, general, 8-29-78
14	2	LS-II-1, 1977
14	3	LS-II-2, 11-8-77
14	4	LS-II-3, 11-8-77
14	5	LS-II-4, 11-8-77
14	6	LS-II-5, 11-10-77
14	7	LS-II-6, 11-11-77
14	8	LS-II-7, 11-11-77
14	9	LS-II-8, 12-9-77
14	10	LS-II-9, 12-9-77
14	11	LS-II-10, 12-9-77
14	12	LS-II-11,12,13, 2-24-78
14	13	LS-II-14,15,16, 4-3-78
14	14	LS-II-17, 4-7-78
14	15	LSB-2, 1979
14	16	LSB-3, 1977
14	17	LSB-4, 1977
14	18	LSB-5, 1977
14	19	LSB6-10, 1977
		MG series, 1973, 1988-1989
14	20	Extracting rat brain containing 3H-MG with hexane and chloroform by H. Nakanishi, 1988-1989
14	21	HIGH std.-2, 14c-MG, 10-2-78
14	22	HIGH-STD-3, 14c-MG, 10-2-78
14	23	MG and hypothalam atlas [computer disk], n.d.
14	24	MG series '73, 1973
14	25	MG-1, 5' cont., 1973
14	26	MG-2, 10' -- cont., 1973
14	27	MG-3, 20' -- cont., 1973
14	28	MG-4, 30' -- cont., 1973
14	29	MG-5 (C14), 2 hrs., 1973
14	30	MG-6 (C14), 1 min., 1973
14	31	MG 7 (C14), 15' cont., 1973
14	32	MG-8 (C14), 60' cont., 1973
14	33	MG-9, 45' cont., 1973
14	34	MG-10 (C14), 4' -- cont., 1973
14	35	MG-11 (C14), 45' -- cont., 1973
14	36	MG-12 (C14), 40' -- bol. C.S.F., 1973
14	37	MG-13 (C14), 4' -- cont., 1973
14	38	MG-14 (C14), 50' -- bol. C.S.F., 1973
14	39	MG-15, 75' -- bol. C.S.F., 1973
14	40	MG-16, 120' -- bol. C.S.F., 1973
14	41	MG-17, 60' -- bol. C.S.F., 1973
14	42	MG-18, 240' -- bol. C.S.F., 1973
14	43	MG-101 and 102, 30' -- B -- 51 u., 1973
14	44	MG-103 and 104, 45' -- B -- 76 uc., 1973
14	45	MG-105, B -- 120' -- 51 uc., 1973
14	46	MG-106 and 107, B - 45' -- 51 uc., 1973
14	47	MG-108, B -- 120' -- 51 uc., 1973
14	48	MG-109 and 110, B -- 60 -- 51 uc., 1973
14	49	MG-111 and 112, B -- 75' -- 51 uc., 1973
14	50	MG-113 and 114, B -- 90' -- 51 uc., 1973
		MSG series, 1978
14	51	MSG-01, 6-22-78
14	52	MSG-03, 7-10-78
14	53	MSG-04, 7-11-78
14	54	MSG-05, 7-11-78
14	55	MSG-06, 7-12-78
14	56	MSG-07, 7-12-78 (experiment stop)
14	57	MSG-1, 1-11-78
14	58	MSG-2, 2-7-78
14	59	MSG-3, 2-13-78
14	60	MSG-4, 2-25-78
14	61	MSG-5, 4-4-78
14	62	MSG-6, 4-18-78
14	63	MSG-7, 5-3-78
		NA24 series, 1956-1957
14	64	Bankson, Frederick N.C. -- LBF -- Na24, 1956
14	65	Binkley, Linda N.C. -- LBF -- Na24, 1956
14	66	Brandt, Mildred N.C. -- LBF -- Na24, 1957
14	67	Buck, Jean PN -- LBF -- Na24, 1956
14	68	Busenitz, Donald N.C. -- LBF -- Na24, 1956
14	69	Dunmeyer, Lloyd, M.Dy. -- LBF -- Na24, 1956
14	70	Flickner, Irma N.C. -- LBF Na24, 1957
14	71	Goosen, Warren N.C. -- LBF -- Na24, 1956
14	72	Grim, Nancy N.C., 1957
14	73	Johnson, James M.Dy. -- LBF -- Na24, 1957
14	74	Kelley, Edward M.Dy. -- LBF -- Na24, 1957
14	75	Kidder, Helen PN -- LBF -- Na24, 1956
14	76	Merediz, Laura M.Dy. -- LBF -- Na24, 1956
14	77	Merkey, Phoely N.C. -- LBF -- Na24, 1957
14	78	NA24, 1954
14	79	Na24 -- leg blood flow studies, 1956
14	80	Na24 -- leg blood flow studies -- book 2, 1957
14	81	Peters, A. Joan M.Dy. -- LBF -- Na24, 1957
14	82	Peters, B. Jean M.Dy. -- LBF -- Na24, 1957
14	83	Smith, Ivan N.C. -- LBF -- Na24, 1957
14	84	Steider, Kenneth -- LBF -- Na24, 1956
14	85	Tillman, Joseph P. N. -- LBF -- Na24, 1956
14	86	Wells, John Sch. -- LBF -- Na24, 1956
14	87	Williams, Esther N.C. -- LBF -- Na24, 1956
14	88	Wingert, John N.C. -- LBF -- Na24, 1956
		New born monkey (NBM) series, 1970-1979, 1983-1989
14	89	Assay of monkey blood, 1978
14	90	LCM 6, 9-30-76
14	91	LCM-7, 10-14-76
14	92	LCM 9, 11-18-76
14	93	Monkey K-732-1, 1971
14	94	Monkey K739-2, 1971
14	95	Monkey lumped constant study, no. 1 [photograph], 1976
14	96	Monkey lumped constant study, no. 2, 1976
14	97	Monkey lumped constant study, no 3, 1976
14	98	Monkey lumped constant study, no 4, 1976
14	99	Monkey lumped constant study, no. 5, 1976
14	100	Monkey-control -- misc., 1985-1989
14	101	NBM-101, tarsoraphy at. 2 days, 1976-1985
14	102	NBM-2, rt. eye patched (LCGU) 11-24-78
14	103	NBM-3, LCGU 3, 1976-1977
14	104	NBM-4 [diskette], 1983
14	105	NBM4, new born monkey, LCGU-control, 1976
14	106	NBM-5, 3-15-76 (LCGU control)
15	1	NBM-6, LCGU, 3-22-76
15	2	NBM7 (new born monkey control), 1976
15	3	NBM-8, LCGU-30', r. eye patched, 1978
15	4	Newborn monkey, LCGU control (NBM1), 1976
15	5	PEN. SEIZ.: adult monk. controls + experimentals, 1970
15	6	PEN. SEIZ.: newborn monk. experimentals, 1970
15	7	PEN. SEIZ: newborn monkeys controls, 1970
15	8	Pen-C, 1, 1975
15	9	Series S.M.: laplace transform, 2-DG conscious monkeys, 1976
15	10	Statist. -- new born monkey, 1979
15	11	Stimulated monkey -- summary tables and graphs, n.d.
		PCP series, 1986-1987
15	12	PCP-1 -- 10 mg/kg, 1986
15	13	PCP - 2 Saline 0.36, 1986
15	14	PCP - 3 1 mg/kg, 1988
15	15	PCP - 4 N. Saline, 1986
15	16	PCP - 5 0.3/kg, 1986
15	17	PCP- 6 3mg/kg, 1986
15	18	PCP - 7 1mg/kg, 1987
15	19	PCP - 8 0.1mg/kg, 1987
15	20	PCP - 9 10mg/kg, 1987
15	21	PCP- 10 N.S., 1988
15	22	PCP - 11 3mg/kg, 1986
15	23	PCP - 12 0.3mg/kg, 1986
15	24	PCP - 13 1mg/kg, 1987
15	25	PCP - 14 0.1mg/kg, 1987
15	26	PCP - 15 3.0mg/kg, 1987
15	27	PCP - 16 N.S., 1987
15	28	PCP - 17 0.3mg/kg, 1986
15	29	PCP - 18 10mg/kg, 1986
15	30	PCP - 19 N.S., 1986
15	31	PCP - 20 0.1mg/kg, 1987
15	32	PCP - 21 0.3/kg, 1987
15	33	PCP 21-2, 1987
15	34	PCP - 22 3mg/kg, 1987
15	35	PCP - 23 10mg/kg, 1987
15	36	PCP - 24 N.S., 1987
15	37	PCP - 25 1mg/kg, 1986
15	38	PCP - 26 10mg/kg, 1987
15	39	PCP 27 0.3mg/kg, 1987
15	40	PCP 28 0.1mg/kg, 1988
15	41	PCP Data, 1987
15	42	PCP Raw Data, 1986
		PT series, 1949-1950, 1979-1987
15	43	PT series -- scp*(t)/cp* - scp*dt/T, 1949-1950
15	44	Pulse 2DG experiments -- PT series -- Ken Mori StCp*(t)dt, 1986
15	45	PT series plus experiments -- physiological conditions, 1987
15	46	Summary PT series -- stretch time etc., pulse exp. mori, 1979-1986
15	47	PT-2 -- 60 min. -- July 25, 86, 1980-1986
15	48	PT-6 -- 35 min. -- July 26, 86, 1980-1986
15	49	PT-7 -- 120 min. -- Aug. 4, 86, 1980-1986
15	50	PT-8 -- 60 min. -- Aug. 4, 86, 1980-1986
15	51	PT-9 -- 25 min. -- Aug. 4, 86, 1980-1986
15	52	PT-10 -- 90 min. exp. -- Aug. 5, 86, 1980-1986
15	53	PT-11 -- 35 min. exp. -- Aug. 5, 86, 1980-1986
15	54	PT-12 -- 45 min. exp. -- Aug. 5, 86, 1980-1986
15	55	PT-13 -- 120 min. exp. Aug. 86, 1980-1986
15	56	PT-14 -- 60 min. -- Aug. 6, 86, 1980-1986
15	57	PT-15 -- 25 min. -- Aug. 6, 86, 1980-1986
15	58	PT-16 -- 90 min. exp. -- Aug. 7, 86, 1980-1986
15	59	PT-17 -- 45 min. exp. -- Aug. 7, 86, 1980-1986
15	60	PT-18 -- 35 min. exp. -- Aug. 7, 86, 1980-1986
15	61	PT-20 -- 60 min. exp. -- Aug. 8, 86, 1980-1986
15	62	PT-21 -- Aug. 8, 86, 1985-1986
15	63	PT 22 -- 120 min. exp. -- Aug. 11, 86, 1980-1986
15	64	PT 23 -- 90 min. exp. -- Aug. 11, 86
15	65	PT 24 -- 4-5 min. exp. -- Aug. 11, 86
15	66	PT-25 -- 120 min. exp. -- Aug. 13, 86, 1985-1986
15	67	PT-26 -- 90 min. exp. - Aug. 13, 86
15	68	PT-27 -- 35 m in. exp. -- Aug. 13, 86, 1985-1986
15	69	PT-28 -- 45 min. exp. -- Aug. 14, 86, 1985-1986
15	70	PT-29 -- 25 min. exp. -- Aug. 14, 86, 1985-1986
15	71	PT-31 -- 25 min. -- Nov. 17, 86, 1985-1986
15	72	PT-32 -- 90 min. -- Nov. 18, 86
15	73	PT-33 -- 25 min. -- Nov. 18, 86, 1985-1986
15	74	PT-34- 45 min. exp. -- Nov. 24, 86, 1985-1986
15	75	PT-35 -- 35 min. exp. -- Nov. 24, 86, 1985-1987
15	76	PT-36 -- 35 min. -- Nov. 24, 86, 1985-1987
15	77	PT-37 -- 45 min. -- Nov. 25, 86, 1985-1987
15	78	PT-38 -- 35 min. -- Nov. 25, 86, 1985-1987
15	79	PT-39 -- 45 min. exp. -- Nov. 26, 86, 1985-1986
15	80	PT-40 -- 25 min. exp. -- Nov. 26, 86, 1985-1986
15	81	PT-41 -- 25 min. exp. -- Nov. 26, 86, 1985-1986
15	82	PT-42 -- 60 min. exp. -- Nov. 28, 86, 1985-1986
15	83	PT-43 -- 35 min. exp. -- Nov. 28, 86, 1985-1987
15	84	PT-44 -- 45 min. exp. -- Nov. 28, 86, 1985-1987
15	85	PT series -- parameters with new three rate constants -- K1*=0.232, K2*=0.240, K3*=0.061, 1985-1986
		PX series, 1978
15	86	PX-0 (.42 mg/kg), 5-3-78
15	87	PX-01 (.42 mg/kg), 8.21.78
15	88	PX-02 (.42 mg/kg), 8-21-78
15	89	PX-1 (21 mg/kg, 8.6 mg pulse), 2-8-78
15	90	PX-2 (7.8 mg pulse), 2-29-78
15	91	PX-3 (8.5 mg pulse), 2-29-78
15	92	PX-4 (21 mg/kg, 8.2 mg pulse), 3-15-78
16	1	PX-5 (4.2 mg/kg), 3-30-78
16	2	PX-6 (4.2 mg/kg), 3-30-78
16	3	PX-7 (4.2 mg/kg), 4-5-78
16	4	PX-8 (4.2 mg/kg), 4-12-78
16	5	PX-9 (42 mg/kg), 4-12-78
16	6	Px-10, 4-19-78
16	7	Px-11, 4-19-78
16	8	PX-12 (4.2 mg/kg), 4-27-78
16	9	PX-13 (4.2 mg/kg), 5-9-78
16	10	PX-14 (42 mg/kg), 5-9-78
16	11	PX-15 (4.2 mg/kg), 8-21-78
16	12	PX-16 (21 mg/kg), 8-21-78
16	13	PX-17 (42 mg/kg), 8-25-78
16	14	PX-18 (9 mg/kg), 12-10-78
16	15	PX-19 (9 mg/kg), 12-10-78
16	16	PX-20 (9 mg/kg), 12-11-78
16	17	PX-21 (9 mg/kg), 12-22-78
16	18	PX-22 (9 mg/kg), 12-13-78
		SM series, 1973-1985
16	19	SM-1, B-45'-320 ul -- rt. eye covered and wurtz, 1975
16	20	Series SM-2: unilateral patching, 1973
16	21	SM-2A, B'-45'-100 uc, both eyes opened, 1973-1978
16	22	SM-3, P-45'-250 uc. (rt. eye patched), 1973-1975
16	23	SM-3A, visual: rt. eye removed, P-45'-250 uc, 1973-1975
16	24	SM-4A, both eyes opened and wurtz pattern - P-45'-300 uc, 1973-1975
16	25	Series SM-5: both eyes patched, 1975
16	26	SM-6, 45'-300 mc -- both eyes patched, 1974-1975
16	27	Series SM-7: eyes intact + stimulation, 1974
16	28	SM-8A, 1974-1977
16	29	Series SM-9A: eyes intact + stimulation, 1975-1977
16	30	SM-10, both eyes intact and wurtz pattern, 1974-1975
16	31	SM-11, 1978
16	32	SM-11, both eyes intact and wurtz, pattern, 1974-1977
16	33	Series SM-12: eyes intact + stimulation, 1974-1977
16	34	SM-13, left eye removed and wurtz, 1974
16	35	SM-14, 5-1-75, rt. eye removed and ambient light
16	36	Series SM-15: unilateral enucleation, 1975
16	37	Series SM-16: unilateral enucleation, 1975
16	38	SM-17, 8-7-75 -- left eye patched and wurtz
16	39	Series SM-18: unilateral enucleation
16	40	SM-19, 11-6-75 -- left eye patched and wurtz
16	41	SM-20, 11-20-75 -- left eye patched and wurtz
16	42	SM-21, Dec. 23, 1975 -- rt. eye patched and wurtz [photograph]
16	43	SM-22, Dec. 23 '75 -- left eye removed and wurtz
16	44	SM-23, Jan. 23 '76 -- both eyes open
16	45	SM-24, both eyes patched, Feb. 5 '76
16	46	SM-25, 2-19-76 -- rt. eye patched and wurtz
16	47	SM-26, 3-19-76 -- rt. eye patched and wurtz
16	48	SM-27, 5-28-76 -- both eyes opened and wurtz
16	49	SM-28, Aug. 2 '76
16	50	SM-29, 11-4-76
16	51	SM-30, 12-9-76
17	1	SM-31, 1976-1985
17	2	SM-32, 1-18-77
17	3	SM33 and SM24, densitometry, n.d.
17	4	SM-33, 8-4-77, both eyes occluded
17	5	SSM-1/SSM-3, n.d.
17	6	SSM-2, 1979
17	7	SSM-2, 4-7-77 [diskette]
17	8	SSM-4 (rt. optic tract sectioned), 1977
17	9	SSM-4 [diskette], 1979
		SR series, 1973-1974
17	10	Series SR-1: visual alterations, 1973
17	11	Series SR-1A: visual alterations, 1973
17	12	Series SR-2: visual alterations, 1973
17	13	Series SR-2A: visual alterations, 1973
17	14	Series SR-3: visual alterations, 1973
17	15	Series SR-3A: visual alterations, 1973
17	16	SR-3B (l. eye remove), 1973
17	17	SR-4-I (r-eye remove), 1973
17	18	SR-4-II (l-eye remove), 1973
17	19	S.R.-5, (left eye patched, TOT -- darkness, I.P.S.), 1973
17	20	Series SSR: sciatic nerve stimulation, 1974
		Thyroxine series
17	21	Reprints -- thyroxine, 1956
17	22	Summaries of thyroxine mitochondrial factor studies, 1964-1965
17	23	Summaries thyroxine effects on pyridine nucleotides, 1975
17	24	T4 effect on mitochondrial NAD+, 1970
17	25	Thyroxine -- illustrations [photographs, negatives], n.d.
17	26	Thyroxine -- protein synthesis, 1955-1965
17	27	Thyroxine -- protein synthesis in vivo, 1963-1964
17	28	Thyroxine -- uptake by brain, 1954-1955
17	29	Thyroxine analogues [photographs, negatives], 1963
17	30	Thyroxine effects on NAD+, 1974
17	31	Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 1 of 3], 1974-1975
17	32	Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 2 of 3], 1974-1975
17	33	Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 3 of 3], 1974-1975
17	34	Thyroxine effects on pyridine nucleotides, 1974
17	35	Thyroxine experiments, 1964
18	1	Thyroxine experiments -- book 2, 1957-1958
18	2	Thyroxine experiments -- book 3, 1958
18	3	Thyroxine factor [negatives], n.d.
18	4	Thyroxine iodine studies, 1954-1955
18	5	Thyroxine mechanism -- tables and illus. [photographs, negatives], n.d.
18	6	Thyroxine project -- charts and slides [photographs, negatives], n.d.
18	7	Thyroxine project -- charts and slides [photographs, negatives], n.d.
18	8	Thyroxine solutions, 1959-1964
18	9	Thyroxine solutions II, 1965-1972
18	10-12	Thyroxine-mitochondrial factor -- preparations and properties -- book 1, 1966-1968
		Whisker barrel (WB) series, 1991-1993
18	13	WB i.v. study, statistics, 1992
18	14	01 whisker barrel series: control, 1991
18	15	WB-02 experiment NMA 30 mg/kg, 1991
18	16	WB-03 control, 1991
18	17	WB-04, control, 1991
18	18	WB-05, experiment NMA 30 mg/kg, 1991
18	19	WB-06, exp. normal saline 1.1 ml, 1991
18	20	WB-07, exp. NMA 30 mg/kg, 1991
18	21	WB-08, exp. NMA 30 mg/kg, 1991-1992
18	22	WB-09, control, 1991
18	23	WB-09, control, 1991
18	24	WB-11, exp. NMA 30 mg/kg, 1991
18	25	WB-12, NMA 100 mg/kg, 1991
18	26	WB-13, NMA 100 mg/kg, 1991
18	27	WB-14, NMA 100 mg/kg, 1991
18	28	WB-15, NMA 100 mg/kg i.v., 1991
18	29	WB-16, control (saline + no stimulation), 1991
18	30	WB-17, NMA 30 mg/kg i.v., 1991-1992
18	31	WB-18, control, 1991-1992
18	32	WB-19, saline i.v. + no stimulation, 1991
18	33	WB-20, control, 1991
18	34	WB-21, control, 1991-1992
18	35	WB-22, methyl ester, 1992
18	36	WB-22, methyl ester 30 mg/kg i.v., 1992
18	37	WB-24, control, 1992
18	38	WB-25, NAME, 1992
18	39	WB-26, control (saline i.v. and no stimulation), 1992
18	40	WB-27, NAME, 1992
18	41	WB-28, control, 1992
18	42	WB-29, control, 1992
18	43	WB-30, nitro-L-arginine methylester, 1992
18	44	WB-31, control, 1992
18	45	WB-32, nitro-L-arginine methylester, 1992
18	46	WB-33, NAME, 1992
18	47	WB-34, control, 1992
18	48	WB-35, nitro-L-arginine methylester, 1992
18	49	WB-36, nitro, fast infusion, 1992
18	50	WB-37, control, 1992
18	51	WB-38, nitro-L-arginine M.E., 600 ug/rat, 1992
18	52	WB-39, control (DIR), 1992
18	53	WB-40, nitro (direct), 600 ug/rat, 1992
18	54	WB-41, control (direct), 1992
18	55	WB-42, nitro-L-arginine (direct), 1992
18	56	WB-43, nitro-L-arginine, 600 ug/rat, 1992
18	57	WB-44, control, 1992
18	58	WB-45, nitro-L-arginine, 600 ug/rat, 1992
18	59	WB-46, nitro-L-arginine, 600 ug/rat, 1992
18	60	WB-47, control, 1992
18	61	WB-48, control, 1992
18	62	WB-49, nitro-L-arginine, 600 ug/rat, 1992
18	63	WB-50, control, 1992
18	64	WB-51, nitro-L-arginine, 600 ug/rat, 1992
18	65	WB-52and53, 3H-nitro-L-arginine and intracisternal infusion, 1993
18	66	WB-54, chronic and NAME, 1993
18	67	WB-55, chronic i.p. and NAME, 1993
18	68	WB-56, chronic ad of NAME, 1993
18	69	WB-57, chronic i.p., 1993
18	70	WB-58, chronic i.p., 1993
18	71	WB-59, chronic i.p., 1993
18	72	WB-60, L-NAME chronic i.p., 1993
18	73	WB-61, chronic i.p., 1993
18	74	WB-62, chronic i.p., 1993
18	75	WB-63, saline chronic i.p., 1993
18	76	WB-64, saline chronic i.p., 1993
18	77	WB-65, saline chronic i.p., 1993
18	78	WB-66, saline chronic i.p., 1993
19	1	WB-cisternal infusion, 1992
19	2	WBDG -- DG parity check, 1992
19	3	WBDG-1, 1992
19	4	WBDG-2, 1991-1992
19	5	WBDG-3, 1991-1992
19	6	WBDG-4, 1992
19	7	WBDG-5, 1992
19	8	WBDG-6, 1992
19	9	WBDG-7, 1992
19	10	WBDG-8, 1992-1993
		YOH series, 1978
19	11	YOH-1 (.25 mg/kg/min.), 4-5-78
19	12	YOH-3 (.25 mg/kg/min.) 7-10-78
19	13	YOH-4 (.25 mg/kg/min.), 7-10-78
19	14	YOH-5 (.1 mg/kg/min.), 7-11-78
19	15	YOH-6 (.25 mg/kg/min.), 7-11-78
19	16	YOH-7 (.1 mg/kg/min.), 7-11-78
19	17	YOH-10 (.25 mg/kg/min.), 8-19-78
19	18	YOH-11 (.1 mg/kg/min.), 8-30-78
19	19	YOH-12 (.25 mg/kg/min.), 9-8-78
19	20	YOH-13 (.25 mg/kg/min.), 9-8-78
19	21	YOH-14 (.25 mg/kg/min.), 9-8-78
19	22	YOH-15 (.025 mg/kg/min.), 9-18-78
19	23	YOH-16 (.025 mg/kg/min.), 9-18-78
19	24	YOH-17 (.1 mg/kg/min.), 12-14-78
19	25	YOH-18 (.1 mg/kg/min.), 12-14-78
19	26	YOH-19 (.05 mg/kg/min.), 12-15-78
19	27	YOH-20 (.05 mg/kg/min.), 12-15-78
19	28	YOH-21 (.05 mg/kg/min.), 12-18-78
19	29	YOH-22 (.05 mg/kg/min.), 12-18-78
19	30	YOH-23 (.05 mg/kg/min.), 12-19-78
19	31	YOH-24 (.0025 mg/kg/min.), 12-20-78
19	32	YOH-25 (.025 mg/kg/min.), 12-20-78
19	33	YOH-26 (.025 mg/kg/min.), 12-20-78
19	34	YOH-27 (.0025 mg/kg/min.), 12-21-78
19	35	YOH-28 (.0025 mg/kg/min.), 12-21-78
19	36	YOH-29 (.0025 mg/kg/min.), 12-21-78
		Other experiments, 1952-2003
19	37	1. aging -- CBF -- Normal, 1955-1957
19	38	2. aging -- CBF -- hypertension, 1956
19	39	3. aging -- CBF -- arteriosclerosis, 1956-1957
19	40	4. aging -- CBF -- chronic brain syndrome, 1957-1958
19	41	B. aging -- patient material, 1957-1959
19	42	C. Aging - Statistics, 1958-1959
19	43	C. Aging - Statistics, 1959
19	44	D Aging - Inter Correlations, 1959-1960
19	45	E Aging -- research data, 1959-1960
20	1	ANES series, 1993
20	2	ANES 1-5, Jan. 5-11, 1993
20	3	ANES 6-10, Jan. 12-25,1993
20	4	ANES 11-15, Feb. 1-9, 1993
20	5	ANES 16-20, Feb. 16-23, 1993
20	6	ANES 21-25, March 21-31, 1993
20	7	ANES 26-30, March 9-22, 1993
20	8	ANES31-34, March 23-28, 1993
20	9	ANES, 1992
20	10-11	Arterial curves -- O2 -- C02 series, 1956
20	12-13	Arterial curves -- SCL series [photographs], 1956
20	14	CE-1: lumped constant rat, 5%, CO2 inhal, 1974
20	15	CE-2: lumped constant rat, 5% CO2 inhal., n.d.
20	16	CE-3: lumped constant rat, 5% CO2 inhal., 1975
20	17	CE-4: lumped constant rat, 5% CO2 inhal., 1975
20	18	CK1, 60 min. normal control, 6-15-78
20	19	CK2, 60 min. 6-15-78
20	20	CS-23, 7-10-78
20	21	CS-24, 8-21-78
20	22	CS-26, 12-13-78
20	23	CS-27, 12-14-78
20	24	G5 Ur W5 V4 original rate constants, n.d.
20	25	Parameters (V4 V4 G6 W5) pulse experiments -- new 3 rate constants, 1985
20	26	HYP1 (10%), 1-15-76
20	27	HYP2 (10%), Jan. 15, '76
20	28	HYP-3 (7.5% O2), Jan. 21, '76
20	29	HYP-4 (7.5% O2), Jan. 21, '76
20	30	Hypoxia 10% O2 behavior: observation, 1976
20	31	LCBF summary, n.d.
20	32	LCBF summary for misc. data, n.d.
20	33	Sheet for LCBF, n.d.
20	34	1 washout constant exp., flow rate: 0.8 ml/min., 1991
20	35	2 washout constant exp., flow rate: 1.0 ml/min., 1991
20	36	03 washout constant exp., flow rate: 1.2 ml/min., 1991
20	37	04 washout constant exp., flow rate: 0.6 ml/min., 1991
20	38	05 washout constant exp., flow rate: 1.4 ml/min., 1991
20	39	06 washout constant exp., flow rate: 1.6 ml/min., 1991
20	40	Washout correction for LCBF equation, n.d.
20	41-42	Wynn project -- alleged non-mitochondrial thyroxine stimulation of protein synthesis -- Nov. 9, 70, 1970
20	43	2 Deoxyglucose Studies (Rat, Cat), 1973-1983
20	44	2.5 min., n.d.
20	45	5.0 min., n.d.
20	46	10 min., n.d.
20	47	15 min., n.d.
20	48	30 min., n.d.
20	49	45 min., n.d.
20	50	60 min., n.d.
20	51	90 min., n.d.
20	52	120 min., n.d.
20	53	14C Toluen internal std. -- lot 0060283A, 1986
20	54	14c-warfarin, 1993
20	55	Abrams -- lumped constant data, 1985
20	56	Additional structure morphine, n.d.
20	57	Alfred Benzon symposium, 1990
20	58	Amanda, 12-5-79, 1979
20	59	Amersham standard calibration, 1978
20	60	Analytical ultracentrifuge records [photographs], 1966
20	61	Anesthesia record, n.d.
21	1	Animal phosphate [photographs], 1978
21	2	AP vs. IAP rat summary, n.d.
21	3	Arithmetic mean value of gray structures (pulse experiments), 1979
21	4	Arterial blood studies (Tbl 1) (from Reivitch, et. al.) [slides], 1977
21	5	Astroglial exp. -- amino acid analysis key, 1995
21	6	Astroglial exp. -- Dr. Kaufman's cell extract samples, 1995
21	7	Astroglial exp. -- intracellular A.A., 1995
21	8	Atlas -- 1, 1980
21	9	Amino-acid-analyzen, 1992
21	10	A. V. blood curves -- desaturation curves studies, 1952-1956
21	11	Banzo (sleep control), 1980
21	12	Basil, 6/13/79
21	13	Beckman polygraph calibration, n.d.
21	14	Blank sheets for experiments, n.d.
21	15	Crop, 6-25-79
21	16	Brain development, n.d.
21	17	Bonzo, film 21, 1985
21	18	Brain -- (Gelber) photos and negatives [photographs, negatives], 1967
21	19	Calibration of plastic standards, 1969-1975
21	20	Calibration of standards, n.d.
21	21	Calibration standards using the "10" and "new low" standards, 1986
21	22	Catheter -- calibration exp., 1991-1992
21	23	Catheter smear collection, n.d.
21	24	Caveness study materials [photographs], n.d.
21	25	CCK -- vagotomized, 1980
21	26	Chico, 1980-1984
21	27	Chr. Li-1, 5-27-80
21	28	Chronic -- nitro i.p., 1993
21	29-30	Chronic i.p. of L-NAME series vol. 1-2, 1993
21	31	Clinical trials of barbiturates in rats, 1972
21	32	Collaboration -- Bill Eckelman and Juntendo Univ., 1999
21	33	Collaboration -- Dr. David M. Cohen, 2000-2003
21	34	Collaboration -- Dr. Rolf Gruetter -- Univ. of Minnesota, 1999-2001
21	35	Collaboration -- SuperGen, 1999-2000
21	36	Dee, film 8-35, 1978
21	37	Dee, film no. 7-35, 1979
21	38-39	Densitometric calibration curves, 1953-1955
21	40	Densitometry 1, 1953-1954
21	41	Densitometry 2, 1954
22	1	Deoxyglucose review, 1980-1981
22	2	Directories -- disk and tape, 1985
22	3	Discarded animals, 1972
22	4	Dreamless, film 17, n.d.
22	5	Dreamless, 1980
22	6	ECF mixed culture (counting data), 1995
22	7	ECG, EOG and EMG (from Reivitch, et. Al.) [Slides], 1985
22	8	Effects of barbiturates on blood gases, n.d.
22	9	Effects of epinephrine on blood glucose, 1958-1959
22	10	Equilibrium, n.d.
22	11	ER-M, C-31'-236 uc., 1973-1974
22	12	Exp. CC1, 1980
22	13	Exp. CC2, 1980
22	14	Exp. CC5, 1980
22	15	Exp. CR2, 1980
22	16	Exp. CR3, 1980
22	17	Exp. CR4, 1980
22	18	Exp. CR6, 1980
22	19	Exp. CR7, 1980
22	20	Experiment 6: raw data -- nucleotide separation by high voltage electrophoresis, 1970
22	21-22	Factor preparation and properties -- book 2, 1968-1974
22	23	Factor TLC scans, 1969
22	24	Failed experiment, Aug. 22, 1991, 1991
22	25	G5 U4 with new 3 rate constants -- Ki*=.232, K2*=.240, K3*=0.61, 1985
22	26	GEE -- experiment work sheep, 1978-1979
22	27	GEE file no. 7-33, 1979-1980
22	28	Glucose deter.: Beckman vs. Gilford, 1975
22	29	Glucose deter.: with glass vs. Eppendorf pipets, 1975
22	30	Glucose determination (spectrophotometer), n.d.
22	31	Glucose determination: glucose oxidase method, n.d.
22	32	Glucose determination: miscellaneous, 1973-1975
22	33	GU-BMF (multi-film program), n.d.
22	34	Guide to reading auto radiographs, n.d.
22	35	Hemoglobinometry, 1979
22	36	HG misc., 1980
22	37	High-std-1, 14c meth. Glucose, 1978
22	38	History: rat thyroidectomies, 1960-1966
22	39	Hydroxybuty rate assay, 1969
22	40	Hyperinsulinemia experiments, 1980
22	41	Info. on micropipettes and pumps, 1973
22	42	Insulin hypoglycemia (50 uci/animal), n.d.
22	43	Internal standard, 1985
22	44	L.S. brain -- I, 1977
22	45	Laplace transform -- technical info., 1975
22	46	Liquid scintillation media, 1974
22	47	List of research projects planned, n.d.
22	48	Low standard I graph, 1977
22	49	LSD-DG series, 1975-1976
22	50	M. Shionohara -- summarized date, 1979
22	51	Manuscript -- Dr. Sokoloff [photographs], n.d.
22	52	Marburg slides, n.d.
22	53	Mean weighted average (GU) -- square exp. (GU was calculated with weighted average of tissue conce.), 1979
22	54	Mean weighted average of GU (GU was directly calculated by image processor), n.d.
22	55	Metabolic maturation of the brain in relation to asphyxia neonatorum, 1963-1964
22	56	Milt, 6-14-79, 1979
22	57	Milt, film no. 1-32, 1979-1982
22	58	Misc. papers, 1979-1980
22	59	Miscellaneous statistical analyses, 1960
22	60	Mixed and astroglial culture, 1995
22	61	Morphine summary, n.d.
22	62	MTZ-1, Dec. 1, 1975
22	63	MTZ-2, Dec. 2, 1975
22	64	N.E.N. standard calibration, 1978-1979
23	1	NH3 - 1-3, HF - 1-2, GD - 1-3, DLX, DX 1-4 Rats [ X- Rays], 1977
23	2	N.O.S. assay, 1992-1993
23	3	Nitro i.p. -- enzyme assay, 1993
23	4	No synthase assay, 1992-1993
23	5	NOD, 3-18-80
23	6	Nodoz, 4-8-80 [photographs]
23	7	Nodoz, film 6, 1980
23	8	NOS activity after nitroarginine intracisternal infusion, 1993
23	9	Nose, 3-22-79
23	10	OD vs. con. x time, n.d.
23	11	Olf. Bulb, n.d.
23	12	Original 3-rate constants, 1986
23	13	Parameters (pulse experiments ) 5 rate constants (K4*=0.0014), 1986
23	14	Parameters (pulse experiments) -- 5 rate constants (K4*=0.002), 1986
23	15	Parameters (square exp.) 5 rate constants, 1986
23	16	Parsley, 7-10-80
23	17	Phosphate, 1979
23	18	Phosphate, 1978
23	19	Physiological conditions' summary -- pulse exp., n.d.
23	20	Plasma curves, n.d.
23	21	Poly. fitting -- plastic standards, 1973
23	22	Posh, 8/6/80
23	23	Pulse experiments parameters -- 5 rate constants (K4*=0.001), 1986
23	24	Pump schedule sheet, n.d.
23	25	Puromycin -- originals negatives [negatives], n.d.
23	26	Psychological vs. Physiological, 1961
23	27	Radiochemical specifications, 1967-1974
23	28	Rat DX-4, 1971
23	29	Rate constant experiments, 1970-1992
23	30	Red-outline drawings, n.d.
23	31	REM4, awake cont. cat, 1976
23	32	REM5, 1976
23	33	Reproduce Iadecola's experiment, 1992
48	28	Research medicine [experiment proposal], 1992
23	34	Reza, Sept. 10, 1979
23	35	Ribosomal protein -- orig. photos and neg. [photographs, negatives], n.d.
23	36	Roche system -- originals and photographs [negatives], n.d.
23	37	Rocky, n.d.
23	38	Rocky, 10-26-78
23	39	Rocky, film no. 1-32, 1979
23	40	Sakurada abstract -- effects of immobilization, 1977
23	41	Salicylates -- illus. and negatives [negatives], n.d.
23	42	Series AB: laplace transform, 2 DG. rats: BARB. ANES, 1975
23	43	Series AUD-111: auditory alterations, 1973
23	44	Series AUD-2: auditory alterations, 1974
23	45	Series AUD-3: auditory alterations, 1974
23	46	Series AUD-4: auditory alterations, 1974
23	47	Series CB: laplace transform, 2DG. rats: 5% CO2, 1975
23	48	Series NH: ammonium acetate -- 10 m. moles/kg i.p., 1972
23	49	Series normal: normal values in rats, 1971
23	50	Series R-ER-1 to R-ER-7 -- trial at square wave rats -- conscious, 1974
23	51	Series WB: laplace transform, 2DG rats: conscious, 1975
23	52	Shaky, 12-20-79 [photograph], 1979
23	53	Short counts on Beckman L.S5801, 1985
23	54	Sierra, 1980-1984
23	55	Sleep -- spinial cord, n.d.
24	1	Sleep (end Kennedy files), 1980
24	2	Sleep 1 (fang), 2-13-80, 1980
24	3	Sleep study, 1981-1990
24	4	Snooz, Jan. 5, 1980, 1980
24	5	Sparky -- myelinated [photographs], 1983
24	6	Spot -- sleeping, 2-12-81, 1981
24	7	Standard calibration, 1979
24	8	Standard strip calibration from G. Dauth, neurosci., Univ. of Mich., Feb. 9, 1980, 1980
24	9	Standards, 1979-1983
24	10	Sugar, 1979
24	11	Sugar, film no. 1-28, 1979
24	12	Summarized data for computer analysis, n.d.
24	13	Summary of parameters (pulse exp.) (square exp.), n.d.
24	14	Summary of parameters (square exp), n.d.
24	15	Summary sheets, 1968-1974
24	16-20	Summary tables and graphs, n.d.
24	21	T3 Be Vwa time course data for Dr. Greenhouse, n.d.
24		TAK - CY20 - CY29 [CD-ROMs], n.d.
24	22	Tent rat training record, 1993
24	23	TSC-1, Nov. 10, 1975
24	24	TSC-2, Dec. 1, 1975
24	25	TSC-3, Dec. 2, 1975
24	26	TSC-4, Dec. 4, 1975
24	27	Values of rate constants in the normal conscious albino rat, n.d.
24	28	Visual alteration: enucleation, 1973
24	29	Weighted average concentration -- (pulse experiments) Dr. Shinohara's data, 1986
24	30	Whole blood samples, n.d.
24	31	Windy, 1978
24	32	Windy [photograph], 1978-1979
24	33	Windy, film no. 7-33, 1978
24	34	Winx, 1985
24	35	Winx (sleep control), 1980
24	36	Winx, film 16, 1987